Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 8,399 shares at $177.41 ($1.5M) on 2021-04-26, disclosed to the SEC on 2021-04-27.
Open-market sale of $1.5M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.87 | 580 | $99K | 6.7% |
| 2 | $169.87 | 580 | $99K | 6.7% |
| 3 | $171.05 | 439 | $75K | 5.1% |
| 4 | $171.05 | 439 | $75K | 5.1% |
| 5 | $171.65 | 1 | $172 | 0.0% |
| 6 | $173.03 | 200 |
| $35K |
| 2.3% |
| 7 | $175.03 | 400 | $70K | 4.7% |
| 8 | $175.97 | 551 | $97K | 6.6% |
| 9 | $175.97 | 551 | $97K | 6.6% |
| 10 | $177.41 | 900 | $160K | 10.8% |
| 11 | $178.51 | 1,829 | $326K | 22.1% |
| 12 | $178.51 | 1,829 | $326K | 22.1% |
| 13 | $179.37 | 100 | $18K | 1.2% |
| Total | $175.80 avg | 8,399 | $1.5M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |